Back to results
US 11,883,493 B2Granted
Antibodies specifically binding to MASP-3 for the treatment of various diseases and disorders
AssigneeOmeros Corporation
InventorsW. Jason Cummings, Gregory A. Demopulos, Thomas Dudler, Larry W. Tjoelker, Christi L. Wood, Munehisa Yabuki
Life of this patent
Estimating the term…
Abstract
The present invention relates to MASP-3 inhibitory antibodies and compositions comprising such antibodies for use in inhibiting the adverse effects of MASP-3 dependent complement activation.
Claims17
An isolated antibody, or antigen-binding fragment thereof, that binds to MASP-3 comprising a heavy chain variable region comprising an HC-CDR1, an HC-CDR2, and an HC-CDR3 and a light chain variable region comprising an LC-CDR1, an LC-CDR2, and an LC-CDR3, wherein:
- i) the HC-CDR1 comprises SEQ ID NO:56, the HC-CDR2 comprises SEQ ID NO:58, the HC-CDR3 comprises SEQ ID NO:60 and wherein the LC-CDR1 comprises SEQ ID NO:142, SEQ ID NO:257, SEQ ID NO:258 or SEQ ID NO:259;
- wherein the LC-CDR2 comprises SEQ ID NO:144 and wherein the LC-CDR3 comprises SEQ ID NO:146;
- or
- ii) the HC-CDR1 comprises SEQ ID NO:62, the HC-CDR2 comprises SEQ ID NO:63, SEQ ID NO:67 or SEQ ID NO:69, the HC-CDR3 comprises SEQ ID NO:65 and wherein the LC-CDR1 comprises SEQ ID NO:149, the LC-CDR2 comprises SEQ ID NO:144 and the LC-CDR3 comprises SEQ ID NO:146.
1 more element
Dependencies are inferred from the claim text.